OMNIBUS AMENDMENT No. 3 to TECHNOLOGY LICENSE AGREEMENT and SYSTEM AND LEAD DEVELOPMENT AND TRANSFER AGREEMENTTechnology License Agreement and System and Lead Development and Transfer Agreement • March 15th, 2012 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus
This OMNIBUS AMENDMENT (this “Amendment”) is made as of this 2nd day of February, 2012, by and between (i) MRI Interventions, Inc., a Delaware corporation formerly known as SurgiVision, Inc. (the “Company”), and (ii) Boston Scientific Neuromodulation Corporation, a Delaware corporation formerly known as Advanced Bionics Corporation (“BSN”). Cardiac Pacemakers, Inc. (“CPI”), an affiliate of BSN, joins in the execution of this Amendment for the limited purpose set forth below. Unless otherwise defined herein, capitalized terms used herein shall have the respective meanings set forth in the Development Agreement referred to below.
OMNIBUS AMENDMENT No. 4 to TECHNOLOGY LICENSE AGREEMENT and SYSTEM AND LEAD DEVELOPMENT AND TRANSFER AGREEMENTTechnology License Agreement and System and Lead Development and Transfer Agreement • August 29th, 2014 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus
This OMNIBUS AMENDMENT (this “Amendment”) is made as of this 19th day of March, 2014, by and between (i) MRI Interventions, Inc., a Delaware corporation formerly known as SurgiVision, Inc. (the “Company”), and (ii) Boston Scientific Neuromodulation Corporation, a Delaware corporation formerly known as Advanced Bionics Corporation (“BSN”). Unless otherwise defined herein, capitalized terms used herein shall have the respective meanings set forth in the Development Agreement referred to below.
OMNIBUS AMENDMENT No. 4 to TECHNOLOGY LICENSE AGREEMENT and SYSTEM AND LEAD DEVELOPMENT AND TRANSFER AGREEMENTTechnology License Agreement and System and Lead Development and Transfer Agreement • May 13th, 2014 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus
This OMNIBUS AMENDMENT (this “Amendment”) is made as of this 19th day of March, 2014, by and between (i) MRI Interventions, Inc., a Delaware corporation formerly known as SurgiVision, Inc. (the “Company”), and (ii) Boston Scientific Neuromodulation Corporation, a Delaware corporation formerly known as Advanced Bionics Corporation (“BSN”). Unless otherwise defined herein, capitalized terms used herein shall have the respective meanings set forth in the Development Agreement referred to below.
